Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction.
D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D001919:Bradycardia / Q000139:chemically induced; D001949:Bretylium Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000188:drug therapy
D001949:Bretylium Compounds; D010672:Phenytoin; D008012:Lidocaine; D011342:Procainamide